These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36638909)

  • 21. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.
    Mohanraju P; Makarova KS; Zetsche B; Zhang F; Koonin EV; van der Oost J
    Science; 2016 Aug; 353(6299):aad5147. PubMed ID: 27493190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AcaFinder: Genome Mining for Anti-CRISPR-Associated Genes.
    Yang B; Zheng J; Yin Y
    mSystems; 2022 Dec; 7(6):e0081722. PubMed ID: 36413017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system.
    Wandera KG; Collins SP; Wimmer F; Marshall R; Noireaux V; Beisel CL
    Methods; 2020 Feb; 172():42-50. PubMed ID: 31121300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Search for Origins of Anti-CRISPR Proteins by Structure Comparison.
    Sahakyan H; Makarova KS; Koonin EV
    CRISPR J; 2023 Jun; 6(3):222-231. PubMed ID: 37272863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CRISPR prediction using deep learning reveals an inhibitor of Cas13b nucleases.
    Wandera KG; Alkhnbashi OS; Bassett HVI; Mitrofanov A; Hauns S; Migur A; Backofen R; Beisel CL
    Mol Cell; 2022 Jul; 82(14):2714-2726.e4. PubMed ID: 35649413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species.
    Pawluk A; Staals RH; Taylor C; Watson BN; Saha S; Fineran PC; Maxwell KL; Davidson AR
    Nat Microbiol; 2016 Jun; 1(8):16085. PubMed ID: 27573108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches.
    Yin Y; Yang B; Entwistle S
    mSystems; 2019 Sep; 4(5):. PubMed ID: 31506266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of multiple anti-CRISPRs highlights anti-defense gene clustering in mobile genetic elements.
    Pinilla-Redondo R; Shehreen S; Marino ND; Fagerlund RD; Brown CM; Sørensen SJ; Fineran PC; Bondy-Denomy J
    Nat Commun; 2020 Nov; 11(1):5652. PubMed ID: 33159058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.
    Wiegand T; Karambelkar S; Bondy-Denomy J; Wiedenheft B
    Annu Rev Microbiol; 2020 Sep; 74():21-37. PubMed ID: 32503371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial Arsenal of Antiviral Defenses - Part I.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Mar; 86(3):319-337. PubMed ID: 33838632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs.
    Camara-Wilpert S; Mayo-Muñoz D; Russel J; Fagerlund RD; Madsen JS; Fineran PC; Sørensen SJ; Pinilla-Redondo R
    Nature; 2023 Nov; 623(7987):601-607. PubMed ID: 37853129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
    Hardouin P; Goulet A
    Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Many (Inter)faces of Anti-CRISPRs: Modulation of CRISPR-Cas Structure and Dynamics by Mechanistically Diverse Inhibitors.
    Belato HB; Lisi GP
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses.
    Pons BJ; Dimitriu T; Westra ER; van Houte S
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216084120. PubMed ID: 36669116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary Genomics of Defense Systems in Archaea and Bacteria.
    Koonin EV; Makarova KS; Wolf YI
    Annu Rev Microbiol; 2017 Sep; 71():233-261. PubMed ID: 28657885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
    Wright AV; Nuñez JK; Doudna JA
    Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of Anti-CRISPR Proteins in Genome Editing and Biotechnology.
    Kraus C; Sontheimer EJ
    J Mol Biol; 2023 Jul; 435(13):168120. PubMed ID: 37100169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?
    Ceballos-Garzon A; Muñoz AB; Plata JD; Sanchez-Quitian ZA; Ramos-Vivas J
    Pathog Dis; 2022 Oct; 80(1):. PubMed ID: 36255384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.